Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
6.01
-0.47 (-7.25%)
Mar 31, 2025, 1:39 PM EDT - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $664.34 million as of March 31, 2025. Its market cap has decreased by -2.54% in one year.
Market Cap
664.34M
Enterprise Value
446.68M
1-Year Change
-2.54%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $664.34M, an increase of 434.59%. That is a compound annual growth rate of 42.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 716.29M | -16.86% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |